Cheelcare Upsizes, Closes Private Placement
Analysis based on 8 articles · First reported Jun 11, 2026 · Last updated Jul 03, 2026
The successful private placement by Cheelcare, raising over $3 million, is expected to positively impact its stock price and investor confidence. The funds will support product development and commercialization, potentially leading to increased revenue and market share for Cheelcare, which could attract further investment in the medical devices sector.
Cheelcare Inc., a Canadian innovator in advanced mobility solutions, initially announced a non-brokered private placement to raise up to $1.5 million. Due to strong investor demand, the offering was subsequently upsized to $3.0 million. The company successfully closed the offering, raising aggregate gross proceeds of $3,023,250 through the issuance of 2,015,500 units at $1.50 per unit. Each unit included one common share and one-half of one common share purchase warrant, with warrants exercisable at $2.25 for two years, subject to an acceleration clause. The proceeds will be used for general working capital, product development, and commercialization activities. Directors and officers of Cheelcare participated in the offering, which constituted a related party transaction, with the company relying on exemptions from certain regulatory requirements. The offering is subject to the final acceptance of the TSX Venture Exchange.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard